Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorArslan, Hatice Nilden
dc.contributor.authorOruç, Muhammet Ali
dc.date.accessioned2022-12-30T11:29:50Z
dc.date.available2022-12-30T11:29:50Z
dc.date.issued2022en_US
dc.identifier.citationArslan, H. N., & Oruc, M. A. (2022). Results from a cervical cancer screening program in Samsun, Turkey. BMC Women's Health, 22(1), 1-8.en_US
dc.identifier.issn14726874
dc.identifier.urihttps://doi.org/10.1186/s12905-022-01916-6
dc.identifier.urihttps://hdl.handle.net/20.500.12513/4874
dc.description.abstractBackground: Cervical cancer is a preventable disease. This study aimed to share the results of the national cervical cancer screening program performed in primary health care institutions in Samsun between 2015 and 2019. Methods: Women aged 30–65 years who were screened for cervical cancer in screening centers of Samsun between January 01, 2015, and December 31, 2019, were included in this descriptive study. The data were obtained from the automation program of the “National Human Papilloma Virus (HPV) Laboratory Application” used by the Provincial Directorate of Health Cancer Unit through filtering the completion time of the tests, and all results were evaluated without sampling. Thus, data were presented using descriptive statistics. Results: The mean age of 89,302 women included in the cervical cancer screening program was 45.9 ± 9.0 years. Of the samples obtained from the participants, 1.0% were determined as insufficient material, 94.1% as HPV-negative, and 4.9% as HPV-positive. The most common HPV genotypes were 16, 51, 31, and 52. Of the 4337 HPV-positive women, 74.7% of the pap smear results were negative (including infection, 36.5%), and the most common premalignant lesions were atypical squamous cells of undetermined significance in 7.1% and low-grade squamous intraepithelial lesions in 6.9%. HPV 16/18 was also observed in 31.7% of HPV-positive women. Seven hundred ninety-five women were referred to a specialist physician for further examination and treatment within the scope of the screening algorithm. Conclusion: Detecting HPV-positivity by reaching more women within the national cervical cancer screening program’s scope is vital in fighting against this disease. The effectiveness of cancer screening programs should be increased by ensuring community participation through awareness activities. © 2022, The Author(s).en_US
dc.language.isoengen_US
dc.publisherBioMed Central Ltden_US
dc.relation.isversionof10.1186/s12905-022-01916-6en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCancer screeningen_US
dc.subjectCervical canceren_US
dc.subjectHPVen_US
dc.subjectWomen’s healthen_US
dc.titleResults from a cervical cancer screening program in Samsun, Turkeyen_US
dc.typearticleen_US
dc.relation.journalBMC Women's Healthen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorIDMuhammet Ali Oruç / 0000-0002-4320-8579en_US
dc.identifier.volume22en_US
dc.identifier.issue1en_US
dc.identifier.startpage1en_US
dc.identifier.endpage8en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster